James Investment Research’s SurgePays SURG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.7K Hold
32,500
﹤0.01% 375
2026
Q1
$24.4K Hold
32,500
﹤0.01% 358
2025
Q4
$54.3K Hold
32,500
0.01% 350
2025
Q3
$91.3K Buy
32,500
+13,500
+71% +$38.3K 0.01% 337
2025
Q2
$59.1K Buy
19,000
+6,000
+46% +$16.6K 0.01% 327
2025
Q1
$26.9K Hold
13,000
﹤0.01% 323
2024
Q4
$23.1K Hold
13,000
﹤0.01% 329
2024
Q3
$23.9K Hold
13,000
﹤0.01% 331
2024
Q2
$41.5K Hold
13,000
﹤0.01% 320
2024
Q1
$50K Buy
13,000
+3,000
+30% +$20K 0.01% 314
2023
Q4
$64.5K Hold
10,000
0.01% 297
2023
Q3
$46.8K Buy
+10,000
New +$51.9K 0.01% 281

Other funds holding SURG

James Investment Research's SURG Position: Q2 2026 in Review

James Investment Research held its SurgePays (SURG) position steady in Q2 2026 at 32,500 shares worth $11.7K. The position accounts for ﹤0.01% of the portfolio, ranked #375.

James Investment Research first reported a position in SURG in Q3 2023 and has held it in 12 quarters since. The position peaked at $91.3K in Q3 2025. 6 funds tracked by Wall St. Rank hold SURG as of Q2 2026.

  • James Investment Research held 32,500 shares of SurgePays worth $11.7K as of Q2 2026.
  • James Investment Research left its SurgePays share count unchanged in Q2 2026.
  • SurgePays made up ﹤0.01% of James Investment Research's portfolio in Q2 2026, its #375 holding.
  • James Investment Research first reported a position in SurgePays in Q3 2023 and has held it in 12 quarters since.
  • James Investment Research's SurgePays position peaked at $91.3K in Q3 2025.
  • 6 funds tracked by Wall St. Rank held SurgePays as of Q2 2026.

Based on James Investment Research's 13F filing for Q2 2026, filed 24 Jul 2026.